Marie Sklodowska-Curie Early Stage Researchers (50725)
University of Strathclyde - Strathclyde Institute of Pharmacy and Biomedical Sciences
|Funding for:||UK Students, EU Students|
|Funding amount:||£32,470 per annum|
|Placed on:||6th October 2016|
|Closes:||23rd October 2016|
FTE : 1.0
Term : Fixed - (fixed term for 3 years)
The Strathclyde Institute at the University of Strathclyde in conjunction with GSK Vaccines S.r.l. wishes to appoint a total of 4 Early Stage Researchers (ESR) within a Marie Sklodowska-Curie Innovative Training Network (H2020-MSCA-ITN-2015 Grant Agreement 675370).
You will work on a research project ‘Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines’. This project brings together two cross-sector, world leading teams – GSK Vaccines S.r.l. and the University of Strathclyde – with the objective to equip the next generation of vaccinologists with the skills and tools to deliver vaccines for the 21st Century. PHA-ST-TRAIN-VAC will deliver a unique, multidisciplinary and intersectoral training programme to develop and equip you with the required skills and entrepreneurship to develop new vaccines.
The four projects have been defined in:
ESR1: Structure-based antigen modification for improved efficacy of vaccines preventing infection by Gram-positive Streptococcus agalactiae - Group B Streptococcus (GBS).
ESR2: Design novel delivery systems to probe alternative routes of administration for a self-amplifying RNA-based RSV vaccine.
ESR3: Investigating alternate delivery systems for self-amplifying RNA vaccines targeting RSV.
ESR4: Identification of Group B Streptococcus (GBS) antigens and design of vaccine nanotechnology-based delivery systems to overcome age-associated decline in adaptive immunity.
You will be supported for a total of 3 years of full-time study to undertake a PhD, and you will spend 18 months at each site (University of Strathclyde, Glasgow, Scotland and GSK Vaccines S.r.l. in Siena, Italy). Two ESRs (ESR 2 and 3) will spend 18 months employed by and within the University of Strathclyde and subsequently 18 months employed by and within GSK Vaccines S.r.l. and two ESR (ESR 1 and 4) will spend 18 months employed by and within GSK Vaccines S.r.l. followed by 18 months employed by and within the University of Strathclyde.
You will be required to meet Marie Curie Early Stage Researcher eligibility criteria. In particular, for the two ESRs commencing their research in the University of Strathclyde (ESR 2 and 3), you must not have resided in the UK for more than 12 months in the last 3 years immediately prior to commencing in the role. For the two ESRs commencing their research in GSK Vaccines S.r.l. (ESR 1 and 4), you must not have resided in Italy for more than 12 months in the last 3 years immediately prior to commencing in the role.
In all 4 posts you must not have been awarded a Doctoral Degree and applicants must be in the first four years of their research career.
In addition to the above, you will have an upper second class BSc Honours or MSc degree or equivalent in a relevant life sciences subject. It cannot be more than four years since obtaining your first degree. You will have the ability and motivation to work independently as well as collaboratively in an interdisciplinary team.
* The ESRs will be contractually employed according to UK and Italian legislation and will be covered under the social security scheme of UK and Italy. They will monthly receive a Living Allowance, a Mobility Allowance and a Family Allowance (where applicable) compliant with the applicable EC Marie Skłodowska-Curie Actions-ITN general conditions (see http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/main/h2020-wp1415-msca_en.pdf page 49).
The minimum salary will be approximately £32,470 per annum through the 18-month contract at the University of Strathclyde
Share this PhD